FOLD — AMICUS THERAPEUTICS INC

Ownership history in Athos Capital Ltd  ·  1 quarter on record

This page tracks every 13F SEC filing in which Athos Capital Ltd reported a position in AMICUS THERAPEUTICS INC (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.27% (2025 Q4)
Avg. % of fund
3.27%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 600,000 — — 3.27% $8.5M $14.24
% of Fund (quarterly)    FOLD price (monthly, adj. close)

Other funds also holding FOLD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 10.32% Sand Grove Capital Management LLP 3Y 7Y 7.95% PSquared Asset Management AG 3Y 7Y 6.99% CM Management, LLC 3Y 4.44% Prosight Management, LP 3Y 7Y 3.38% KRYGER CAPITAL Ltd 3Y 3.29% Chicago Capital Management, LLC 3Y 7Y 2.92% Bellevue Group AG 3Y 7Y 2.9% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 2.75% Soleus Capital Management, L.P. 3Y 2.74%
← Back to Athos Capital Ltd Holdings